147 related articles for article (PubMed ID: 33136467)
1. Evaluation of Interleukin-23 and
Rezaeepoor M; Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Behzad M
J Interferon Cytokine Res; 2020 Nov; 40(11):515-523. PubMed ID: 33136467
[TBL] [Abstract][Full Text] [Related]
2. Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.
Liang Y; Jin Y; Li Y
Pediatr Nephrol; 2009 Sep; 24(9):1661-71. PubMed ID: 19350281
[TBL] [Abstract][Full Text] [Related]
3. SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children.
Ostalska-Nowicka D; Smiech M; Jaroniec M; Zaorska K; Zawierucha P; Szaflarski W; Malinska A; Nowicki M
Folia Histochem Cytobiol; 2011; 49(4):719-28. PubMed ID: 22252769
[TBL] [Abstract][Full Text] [Related]
4. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
5. Impact of interleukin-32α on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus.
Borzouei S; Gholamian-Hamadan M; Behzad M
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):268-276. PubMed ID: 36263937
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-Primed hUCMSCs Significantly Reduced Inflammation
Ling X; Wang T; Han C; Wang P; Liu X; Zheng C; Bi J; Zhou X
Front Immunol; 2022; 13():835345. PubMed ID: 35300342
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 1,25(OH)2D3 Effects on FOXP3, ROR-γt, GITR, and CTLA-4 Gene Expression in the PBMCs of Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss (URPL).
Abdollahi E; Saghafi N; Rezaee SA; Rastin M; Jarahi L; Clifton V; Rafatpanah H
Iran Biomed J; 2020 Sep; 24(5):295-305. PubMed ID: 32429643
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
Teramo A; Gattazzo C; Passeri F; Lico A; Tasca G; Cabrelle A; Martini V; Frezzato F; Trimarco V; Ave E; Boscaro E; Piazza F; Facco M; Trentin L; Semenzato G; Zambello R
Blood; 2013 May; 121(19):3843-54, S1. PubMed ID: 23515927
[TBL] [Abstract][Full Text] [Related]
10. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
Piao CH; Song CH; Lee EJ; Chai OH
Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
[TBL] [Abstract][Full Text] [Related]
11. Disturbance in Serum Levels of IL-17 and TGF-β1 and in Gene Expression of ROR-γt and FOX-P3 Is Associated with Pathogenicity of Systematic Lupus Erythematosus.
Ali HN; Alubaidi GT; Gorial FI; Jasim IA
Prague Med Rep; 2022; 123(3):166-180. PubMed ID: 36107445
[TBL] [Abstract][Full Text] [Related]
12. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
13. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
14. Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway.
Al-Qabbaa SM; Qaboli SI; Alshammari TK; Alamin MA; Alrajeh HM; Almuthnabi LA; Alotaibi RR; Alonazi AS; Bin Dayel AF; Alrasheed NM; Alrasheed NM
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047505
[TBL] [Abstract][Full Text] [Related]
15. Changes in T helper cell-related factors in patients with type 2 diabetes mellitus after empagliflozin therapy.
Borzouei S; Moghimi H; Zamani A; Behzad M
Hum Immunol; 2021 Jun; 82(6):422-428. PubMed ID: 33771372
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL-6 family cytokines by SOCS3.
Babon JJ; Varghese LN; Nicola NA
Semin Immunol; 2014 Feb; 26(1):13-9. PubMed ID: 24418198
[TBL] [Abstract][Full Text] [Related]
17. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2.
Singh AK; Khare P; Obaid A; Conlon KP; Basrur V; DePinho RA; Venuprasad K
Nat Commun; 2018 Oct; 9(1):4515. PubMed ID: 30375383
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of SOCS3 in lung CD4+ T cells in a mouse model of chronic PA lung infection and suppression of Th17‑mediated neutrophil recruitment in exogenous SOCS3 transfer in vitro.
Ding FM; Liao RM; Chen YQ; Xie GG; Zhang PY; Shao P; Zhang M
Mol Med Rep; 2017 Jul; 16(1):778-786. PubMed ID: 28560450
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
Ibrahim SSA; Salama MA; Selima E; Shehata RR
Life Sci; 2020 Nov; 260():118261. PubMed ID: 32795539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
